Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,024
Closed -$75K 99
2017
Q1
$75K Buy
+13,024
New +$71.5K 0.02% 105
2016
Q4
Sell
-17,782
Closed -$108K 103
2016
Q3
$108K Buy
17,782
+4,758
+37% +$28.4K 0.03% 114
2016
Q2
$77K Sell
13,024
-27,533
-68% -$148K 0.02% 113
2016
Q1
$210K Sell
40,557
-167,645
-81% -$771K 0.05% 108
2015
Q4
$929K Sell
208,202
-127,753
-38% -$624K 0.19% 70
2015
Q3
$1.65M Buy
335,955
+87,559
+35% +$475K 0.04% 160
2015
Q2
$1.51M Sell
248,396
-85,229
-26% -$527K 0.02% 163
2015
Q1
$1.92M Buy
333,625
+145,093
+77% +$901K 0.03% 172
2014
Q4
$1.17M Sell
188,532
-465,690
-71% -$2.94M 0.01% 205
2014
Q3
$4.29M Sell
654,222
-44,940
-6% -$316K 0.04% 139
2014
Q2
$4.92M Buy
+699,162
New +$5.14M 0.21% 127

Other funds holding ABEV

NatWest Group's ABEV Position: Q2 2017 in Review

NatWest Group sold out of Ambev (ABEV) in Q2 2017, closing a stake of 13,024 shares — an estimated $75K sold.

NatWest Group first reported a position in ABEV in Q2 2014 and held it in 11 quarters. The position peaked at $4.92M in Q2 2014. 301 funds tracked by Wall St. Rank hold ABEV as of Q2 2017.

  • NatWest Group reported no remaining Ambev position as of Q2 2017 after selling out during the quarter.
  • NatWest Group sold 13,024 Ambev shares in Q2 2017, an estimated $75K.
  • NatWest Group first reported a position in Ambev in Q2 2014 and held it in 11 quarters.
  • NatWest Group's Ambev position peaked at $4.92M in Q2 2014.
  • 301 funds tracked by Wall St. Rank held Ambev as of Q2 2017.

Based on NatWest Group's 13F filing for Q2 2017, filed 14 Aug 2017.